Skip to main content

Table 2 Satisfaction regarding aesthetic outcome

From: Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery

Factor

Satisfied

Not satisfied

OR (95% CI)

OR (95% CI)a

OR (95% CI)b

 

n (%)

n (%)

   

Age (years)

 <50

42 (16.9)

4 (12.1)

1

1

1

 ≥50–<65

101 (40.6)

18 (54.5)

1.87 (0.60–5.86)

1.84 (0.58–5.78)

2.02 (0.61–6.71)

 ≥65

106 (42.6)

11 (33.3)

1.09 (0.33–3.61)

0.99 (0.30–3.32)

0.96 (0.27–3.38)

BMI (kg/m2)

 <25

111 (44.5)

12 (36.4)

1

1

1

 ≥25–<30

83 (33.5)

13 (39.4)

1.45 (0.63–3.34)

1.58 (0.68–3.69)

1.57 (0.63–3.91)

 ≥30

54 (21.8)

8 (24.2)

1.37 (0.53–3.55)

1.49 (0.57–3.92)

1.68 (0.59–4.78)

 Missing

1

    

Breast volume (ml)c

 <500

107 (43.7)

14 (42.4)

1

1

 

 ≥500

138 (56.3)

19 (57.6)

1.05 (0.51–2.20)

1.02 (0.43–2.39)

 

 Missing

4

    

Tumour size (mm)c

 <15

120 (48.2)

14 (42.4)

1

1

 

 ≥15

129 (51.8)

19 (57.6)

1.26 (0.61–2.63)

1.16 (0.55–2.45)

 

Specimen weight (g)c

 <63

127 (51.0)

11 (33.3)

1

1

 

 ≥63

122 (49.0)

22 (66.7)

2.08 (0.97–4.48)

2.15 (0.96–4.83)

 

EPBVEd (%)

 <10

78 (31.8)

7 (21.2)

1

1

1

 ≥10–<20

137 (55.9)

16 (48.5)

1.30 (0.51–3.30)

1.29 (0.50–3.33)

1.14 (0.42–3.07)

 ≥20

30 (12.2)

10 (30.3)

3.71 (1.30–10.65)

3.93 (1.34–11.55)

3.05 (0.98–9.47)

 Missing

4

    

Axillary clearance

    

 No

212 (85.5)

22 (66.7)

1

1

1

 Yes

36 (14.5)

11 (33.3)

2.94 (1.32–6.59)

3.02 (1.32–6.90)

2.87 (1.20–6.83)

 Missing

1

    

Re-excision

 No

234 (94.0)

28 (84.8)

1

1

1

 Yes

15 (6.0)

5 (15.2)

2.79 (0.94–8.25)

3.09 (1.01–9.48)

3.02 (0.92–9.89)

Infection

 No

235 (94.4)

28 (84.8)

1

1

1

 Yes

14 (5.6)

5 (15.2)

3.00 (1.00–8.95)

2.92 (0.94–9.04)

2.65 (0.83–8.50)

Radiotherapy

 No

37 (14.9)

3 (9.1)

1

1

 

 Yes

212 (85.1)

30 (90.9)

1.75 (0.51–6.01)

1.48 (0.42–5.26)

 

Chemotherapy

 No

220 (88.4)

29 (87.9)

1

1

 

 Yes

29 (11.6)

4 (12.1)

1.05 (0.34–3.19)

1.10 (0.34–3.54)

 

Hormonal therapy

 No

112 (45.0)

13 (39.4)

1

1

 

 Yes

137 (55.0)

20 (60.6)

1.26 (0.60–2.64)

1.25 (0.59–2.66)

 

Quadrant

 UOQ

127 (51.2)

20 (60.6)

1

1

 

 LOQ

49 (19.8)

4 (12.1)

0.52 (0.17–1.61)

0.51 (0.16–1.57)

 

 LIQ

20 (8.1)

4 (12.1)

1.30 (0.40–4.26)

1.29 (0.39–4.24)

 

 UIQ

50 (20.2)

5 (15.2)

0.61 (0.22–1.73)

0.59 (0.21–1.67)

 

 Central

2 (0.8)

0 (0.0)

–

–

 

 Missing

1

    
  1. aAdjusted for age and BMI. bAdjusted for age, BMI, EPBVE, axillary clearance, re-excision, and infection. cGroups divided at the median. dEstimated percentage of breast volume excised
  2. UOQ upper outer quadrant, LOQ lower outer quadrant, LIQ lower inner quadrant, UIQ upper inner quadrant
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us